Two biomarkers point to swab test for schizophrenia, Pg14

Key Highlights:

• Researchers identified Sp4 mRNA and HSP60 as potential biomarkers for schizophrenia detectable via cheek swab.
• Schizophrenia patients showed significantly higher levels of Sp4 mRNA and HSP60 in mouth cells compared to healthy individuals.
• Higher Sp4 levels correlated with more severe symptoms and poorer memory, while elevated HSP60 predicted slower reaction times.

Detailed Insights:

• The discovery of these biomarkers could lead to a less invasive diagnostic method for schizophrenia, replacing current invasive tests.
• Sp4 mRNA is a transcription factor involved in neuronal development and synaptic plasticity, potentially linking its elevated levels to the cognitive deficits seen in schizophrenia.
• HSP60, a heat shock protein, is involved in cellular stress response and immune modulation, suggesting a possible link between immune dysregulation and schizophrenia.
• Further research is needed to validate these findings in larger cohorts and to explore the potential of these biomarkers for early diagnosis and personalized treatment of schizophrenia.

Scientific/Technical Concepts Involved:

• mRNA: Messenger ribonucleic acid, carries genetic code from DNA to ribosomes for protein synthesis.
• Biomarker: A measurable indicator of a biological state or condition.
• Transcription Factor: A protein that binds to specific DNA sequences, controlling the rate of gene transcription.